Geratherm Medical Future Growth

Future criteria checks 3/6

Geratherm Medical is forecast to grow earnings and revenue by 89.5% and 1.9% per annum respectively. EPS is expected to grow by 92.8% per annum. Return on equity is forecast to be 1.8% in 3 years.

Key information

89.5%

Earnings growth rate

92.8%

EPS growth rate

Medical Equipment earnings growth	22.6%
Revenue growth rate	1.9%
Future return on equity	1.8%
Analyst coverage	Low
Last updated	11 Nov 2024

Recent future growth updates

No updates

Recent updates

No updates

Earnings and Revenue Growth Forecasts

LSE:0EL9 - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	19	1	2	3	1
12/31/2025	18	0	3	4	1
12/31/2024	18	0	4	5	1
6/30/2024	18	-1	-2	0	N/A
3/31/2024	20	0	-1	1	N/A
12/31/2023	22	1	0	1	N/A
9/30/2023	24	1	1	2	N/A
6/30/2023	26	1	1	2	N/A
3/31/2023	26	1	1	3	N/A
12/31/2022	26	1	0	3	N/A
9/30/2022	25	0	-1	2	N/A
6/30/2022	24	0	0	2	N/A
3/31/2022	24	0	0	1	N/A
12/31/2021	25	0	0	1	N/A
9/30/2021	27	2	1	2	N/A
6/30/2021	27	2	0	2	N/A
3/31/2021	29	2	0	3	N/A
12/31/2020	28	2	1	4	N/A
9/30/2020	25	1	0	3	N/A
6/30/2020	24	1	0	3	N/A
3/31/2020	20	0	-1	2	N/A
12/31/2019	20	1	-1	2	N/A
9/30/2019	22	1	-2	2	N/A
6/30/2019	22	0	-3	1	N/A
3/31/2019	23	1	-3	2	N/A
12/31/2018	22	1	-3	2	N/A
9/30/2018	21	1	-2	2	N/A
6/30/2018	21	1	1	4	N/A
3/31/2018	20	1	N/A	3	N/A
12/31/2017	21	1	N/A	2	N/A
9/30/2017	22	2	N/A	2	N/A
6/30/2017	21	2	N/A	1	N/A
3/31/2017	22	3	N/A	1	N/A
12/31/2016	22	2	N/A	1	N/A
9/30/2016	22	2	N/A	2	N/A
6/30/2016	23	3	N/A	2	N/A
3/31/2016	22	2	N/A	3	N/A
12/31/2015	22	3	N/A	4	N/A
9/30/2015	21	2	N/A	3	N/A
6/30/2015	21	2	N/A	3	N/A
3/31/2015	20	2	N/A	2	N/A
12/31/2014	19	2	N/A	1	N/A
9/30/2014	18	2	N/A	1	N/A
6/30/2014	17	1	N/A	0	N/A
3/31/2014	16	1	N/A	1	N/A
12/31/2013	17	1	N/A	2	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0EL9 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: 0EL9 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 0EL9 is expected to become profitable in the next 3 years.

Revenue vs Market: 0EL9's revenue (1.9% per year) is forecast to grow slower than the UK market (3.5% per year).

High Growth Revenue: 0EL9's revenue (1.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0EL9's Return on Equity is forecast to be low in 3 years time (1.8%).